LK
Anixa Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ovarian Cancer CER-T | Recurrent Ovarian Cancer | Phase 1 |
| Breast Cancer Vaccine | Triple-Negative Breast Cancer (TNBC) | Phase 1b |
| Ovarian Cancer Vaccine | Ovarian Cancer | Discovery |
| Multi-Cancer Vaccine Discovery | Lung, Colon, Prostate Cancers | Discovery |
Leadership Team at Anixa Biosciences
AK
Amit Kumar, Ph.D.
Chairman & Chief Executive Officer
MC
Michael Catelani
President, COO & CFO
PD
Pamela D. Garzone, Ph.D.
Chief Development Officer
LT
Lew Titterton
Lead Independent Director
AB
Arnold Baskies, MD
Director
EG
Emily Gottschalk
Director
MS
Michael Shepard, Ph.D.
Scientific Advisor
JC
Jose Conejo-Garcia, MD, Ph.D.
Scientific Advisor
MD
Marco Davila, MD, Ph.D.
Scientific Advisor
DA
Daniel Abate-Daga, Ph.D.
Scientific Advisor